{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:04:22Z","timestamp":1791014662782,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/ncprheum0165","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T16:50:19Z","timestamp":1147798219000},"page":"252-261","source":"Crossref","is-referenced-by-count":105,"title":["The management of Sj\u00f6gren's syndrome"],"prefix":"10.1038","volume":"2","author":[{"given":"Clio P","family":"Mavragani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki M","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos M","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncprheum0165_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"SS Kassan","year":"2004","unstructured":"Kassan SS and Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sj\u00f6gren's syndrome. Arch Intern Med 164: 1275\u20131284","journal-title":"Arch Intern Med"},{"key":"BFncprheum0165_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C et al. (2002) Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0165_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000024423","volume":"123","author":"CP Mavragani","year":"2000","unstructured":"Mavragani CP et al. (2000) Sj\u00f6gren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. Int Arch Allergy Immunol 123: 46\u201357","journal-title":"Int Arch Allergy Immunol"},{"key":"BFncprheum0165_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/ard.59.1.54","volume":"59","author":"R Manthorpe","year":"2000","unstructured":"Manthorpe R et al. (2000) Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA\/Ro and anti-SSB\/La antibodies in Sj\u00f6gren's syndrome? Ann Rheum Dis 59: 54\u201360","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0165_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN et al. (2000) Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren's syndrome. Semin Arthritis Rheum 29: 296\u2013304","journal-title":"Semin Arthritis Rheum"},{"key":"BFncprheum0165_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11882-005-0077-x","volume":"5","author":"M Samarkos","year":"2005","unstructured":"Samarkos M and Moutsopoulos HM (2005) Recent advances in the management of ocular complications of Sj\u00f6gren's syndrome. Curr Allergy Asthma Rep 5: 327\u2013332","journal-title":"Curr Allergy Asthma Rep"},{"key":"BFncprheum0165_CR7","first-page":"924","volume":"29","author":"WW Kalk","year":"2002","unstructured":"Kalk WW et al. (2002) Oral and ocular manifestations in Sj\u00f6gren's syndrome. J Rheumatol 29: 924\u2013930","journal-title":"J Rheumatol"},{"key":"BFncprheum0165_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/01.ico.0000133993.14768.a9","volume":"23","author":"J Tauber","year":"2004","unstructured":"Tauber J et al. (2004) Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Cornea 23: 784\u2013792","journal-title":"Cornea"},{"key":"BFncprheum0165_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1067\/moe.2002.126017","volume":"94","author":"WW Kalk","year":"2002","unstructured":"Kalk WW et al. (2002) Parotid sialography for diagnosing Sj\u00f6gren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94: 131\u2013137","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"BFncprheum0165_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.tripleo.2003.07.010","volume":"97","author":"SR Porter","year":"2004","unstructured":"Porter SR et al. (2004) An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97: 28\u201346","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"BFncprheum0165_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6890-5-4","volume":"5","author":"AM Pedersen","year":"2005","unstructured":"Pedersen AM et al. (2005) Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sj\u00f6gren's syndrome. BMC Clin Pathol 5: 4","journal-title":"BMC Clin Pathol"},{"key":"BFncprheum0165_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0030-4220(89)90218-1","volume":"68","author":"YL Hernandez","year":"1989","unstructured":"Hernandez YL and Danils TE (1989) Oral candidiasis in Sj\u00f6gren's syndrome: prevalence, clinical correlations, and treatement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 68: 324\u2013329","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"BFncprheum0165_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1034\/j.1600-051x.2000.027004231.x","volume":"27","author":"EA Bootsi","year":"2000","unstructured":"Bootsi EA et al. (2000) Dental and periodontal status of Sj\u00f6gren's syndrome. J Clin Periodontol 27: 231\u2013235","journal-title":"J Clin Periodontol"},{"key":"BFncprheum0165_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/154411130301400305","volume":"14","author":"A Vissink","year":"2003","unstructured":"Vissink A et al. (2003) Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14: 199\u2013212","journal-title":"Crit Rev Oral Biol Med"},{"key":"BFncprheum0165_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/10454411000110020301","volume":"11","author":"AN Ellepola","year":"2000","unstructured":"Ellepola AN and Samaranayake LP (2000) Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 11: 172\u2013198","journal-title":"Crit Rev Oral Biol Med"},{"key":"BFncprheum0165_CR16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/cncr.10348","volume":"94","author":"PA Johnstone","year":"2002","unstructured":"Johnstone PA et al. (2002) Acupuncture for xerostomia: clinical update. Cancer 94: 1151\u20131156","journal-title":"Cancer"},{"key":"BFncprheum0165_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.homp.2005.03.002","volume":"94","author":"S Haila","year":"2005","unstructured":"Haila S et al. (2005) Effects of homeopathic treatment on salivary flow rate and subjective symptoms in patients with oral dryness: a randomized trial. Homeopathy 94: 175\u2013181","journal-title":"Homeopathy"},{"key":"BFncprheum0165_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"FB Vivino","year":"1999","unstructured":"Vivino FB et al. (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159: 174\u2013181","journal-title":"Arch Intern Med"},{"key":"BFncprheum0165_CR19","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/ard.2002.003889","volume":"62","author":"N Tsifetaki","year":"2003","unstructured":"Tsifetaki N et al. (2003) Oral pilocarpine for the treatment of ocular symptoms in patients with Sj\u00f6gren's syndrome: a randomised 12 week controlled study. Ann Rheum Dis 62: 1204\u20131207","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0165_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","volume":"162","author":"RS Fife","year":"2002","unstructured":"Fife RS et al. (2002) Cevimeline for the treatment of xerostomia in patients with Sj\u00f6gren syndrome: a randomized trial. Arch Intern Med 162: 1293\u20131300","journal-title":"Arch Intern Med"},{"key":"BFncprheum0165_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/art.510","volume":"46","author":"D Petrone","year":"2002","unstructured":"Petrone D et al. (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sj\u00f6gren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46: 748\u2013754","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0165_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","volume":"138","author":"M Ono","year":"2004","unstructured":"Ono M et al. (2004) Therapeutic effect of cevimeline on dry eye in patients with Sj\u00f6gren's syndrome: a randomized, double-blind clinical study. Am J Ophthalmol 138: 6\u201317","journal-title":"Am J Ophthalmol"},{"key":"BFncprheum0165_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/art.20540","volume":"51","author":"SR Pillemer","year":"2004","unstructured":"Pillemer SR et al. (2004) Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sj\u00f6gren's syndrome. Arthritis Rheum 51: 601\u2013604","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0165_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s002810100070","volume":"23","author":"NM Moutsopoulos","year":"2001","unstructured":"Moutsopoulos NM and Moutsopoulos HM (2001) Therapy of Sj\u00f6gren's syndrome. Springer Semin Immunopathol 23: 131\u2013145","journal-title":"Springer Semin Immunopathol"},{"key":"BFncprheum0165_CR25","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1001\/archinte.164.21.2387-b","volume":"164","author":"X Roblin","year":"2004","unstructured":"Roblin X et al. (2004) Celiac disease must be evaluated in patients with Sj\u00f6gren syndrome. Arch Intern Med 164: 2387","journal-title":"Arch Intern Med"},{"key":"BFncprheum0165_CR26","first-page":"96","volume":"31","author":"MM Zandbelt","year":"2004","unstructured":"Zandbelt MM et al. (2004) Etanercept in the treatment of patients with primary Sj\u00f6gren's syndrome: a pilot study. J Rheumatol 31: 96\u2013101","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"BFncprheum0165_CR27","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1177\/0961203396005001071","volume":"5","author":"MN Manoussakis","year":"1996","unstructured":"Manoussakis MN and Moutsopoulos HM (1996) Antimalarials in Sj\u00f6gren's syndrome\u2014the Greek experience. Lupus 5 (Suppl 1): S28\u2013S30","journal-title":"Lupus"},{"key":"BFncprheum0165_CR28","first-page":"618","volume":"17","author":"FN Skopouli","year":"1990","unstructured":"Skopouli FN et al. (1990) Raynaud's phenomenon in primary Sj\u00f6gren's syndrome. J Rheumatol 17: 618\u2013620","journal-title":"J Rheumatol"},{"key":"BFncprheum0165_CR29","first-page":"726","volume":"29","author":"M Garcia-Carrasco","year":"2002","unstructured":"Garcia-Carrasco M et al. (2002) Raynaud's phenomenon in primary Sj\u00f6gren's syndrome. Prevalence and clinical characteristics in a series of 320 patients. J Rheumatol 29: 726\u2013730","journal-title":"J Rheumatol"},{"key":"BFncprheum0165_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1023\/B:DDAS.0000017446.64582.62","volume":"49","author":"F Volter","year":"2004","unstructured":"Volter F et al. (2004) Esophageal function and Sj\u00f6gren's syndrome. Dig Dis Sci 49: 248\u2013253","journal-title":"Dig Dis Sci"},{"key":"BFncprheum0165_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1001\/jama.294.12.1534","volume":"294","author":"CN Ford","year":"2005","unstructured":"Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294: 1534\u20131540","journal-title":"JAMA"},{"key":"BFncprheum0165_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00005792-200007000-00005","volume":"79","author":"A Goules","year":"2000","unstructured":"Goules A et al. (2000) Clinically significant and biopsy-documented renal involvement in primary Sj\u00f6gren syndrome. Medicine (Baltimore) 79: 241\u2013249","journal-title":"Medicine (Baltimore)"},{"key":"BFncprheum0165_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3949\/ccjm.64.10.523","volume":"64","author":"HM Linardaki G and Moutsopoulos","year":"1997","unstructured":"Linardaki G and Moutsopoulos HM (1997) The uncertain role of immuno-suppressive agents in Sj\u00f6gren's syndrome. Cleve Clin J Med 64: 523\u2013526","journal-title":"Cleve Clin J Med"},{"key":"BFncprheum0165_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1440-1827.2005.01790.x","volume":"55","author":"T Matsumoto","year":"2005","unstructured":"Matsumoto T et al. (2005) Autoimmune hepatitis in primary Sj\u00f6gren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sj\u00f6gren's syndrome. Pathol Int 55: 70\u201376","journal-title":"Pathol Int"},{"key":"BFncprheum0165_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/ard.58.1.61","volume":"58","author":"SA Papiris","year":"1999","unstructured":"Papiris SA et al. (1999) Lung involvement in primary Sj\u00f6gren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 58: 61\u201364","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0165_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/ard.2003.019497","volume":"63","author":"FC Soliotis","year":"2004","unstructured":"Soliotis FC et al. (2004) Central nervous system involvement in Sj\u00f6gren's syndrome. Ann Rheum Dis 63: 616\u2013620","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0165_CR37","first-page":"1552","volume":"30","author":"J Font","year":"2003","unstructured":"Font J et al. (2003) Pure sensory neuropathy in primary Sj\u00f6gren's syndrome. Long-term prospective follow-up and review of the literature. J Rheumatol 30: 1552\u20131557","journal-title":"J Rheumatol"},{"key":"BFncprheum0165_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1196\/annals.1361.121","volume":"1051","author":"Y Levy","year":"2005","unstructured":"Levy Y et al. (2005) Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Ann NY Acad Sci 1051: 779\u2013786","journal-title":"Ann NY Acad Sci"},{"key":"BFncprheum0165_CR39","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/rheumatology\/keh248","volume":"43","author":"M Voulgarelis","year":"2004","unstructured":"Voulgarelis M et al. (2004) Combined therapy with rituximab plus cyclophosphamide\/ doxorubicin\/ vincristine\/ prednisone (CHOP) for Sj\u00f6gren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas. Rheumatology (Oxford) 43: 1050\u20131053","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0165_CR40","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1136\/ard.2004.029694","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE et al. (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64: 913\u2013920","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0165_CR41","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/art.21260","volume":"52","author":"J Pijpe","year":"2005","unstructured":"Pijpe J et al. (2005) Rituximab treatment in patients with primary Sj\u00f6gren's syndrome: an open-label phase II study. Arthritis Rheum 52: 2740\u20132750","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0165_CR42","doi-asserted-by":"crossref","unstructured":"Voulgarelis M et al. (2005) Long-term remission of Sj\u00f6gren's syndrome-associated aggressive B-cell non-Hodgkin's lymphomas following administration of combined B-cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann Rheum Dis [doi: 10.1136\/ard.2005.046193]","DOI":"10.1136\/ard.2005.046193"},{"key":"BFncprheum0165_CR43","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/art.10434","volume":"46","author":"M Voulgarelis","year":"2002","unstructured":"Voulgarelis M et al. (2002) 2-chloro-2'-deoxyadenosine in the treatment of Sj\u00f6gren's syndrome-associated B cell lymphoproliferation. Arthritis Rheum 46: 2248\u20132249","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0165_CR44","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1002\/art.20472","volume":"50","author":"Y Hayashi","year":"2004","unstructured":"Hayashi Y et al. (2004) Effective treatment of a mouse model of Sj\u00f6gren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody. Arthritis Rheum 50: 2903\u20132910","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0165_CR45","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/labinvest.3700234","volume":"85","author":"K Motegi","year":"2005","unstructured":"Motegi K et al. (2005) Expression of aquaporin-5 in and fluid secretion from immortalized human salivary gland ductal cells by treatment with 5-aza-2'-deoxycytidine: a possibility for improvement of xerostomia in patients with Sj\u00f6gren's syndrome. Lab Invest 85: 342\u2013353","journal-title":"Lab Invest"},{"key":"BFncprheum0165_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-3083.2005.01593.x","volume":"61","author":"BT Kurien","year":"2005","unstructured":"Kurien BT et al. (2005) Induction of oral tolerance in experimental Sj\u00f6gren's syndrome autoimmunity. Scand J Immunol 61: 418\u2013425","journal-title":"Scand J Immunol"},{"key":"BFncprheum0165_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/ard.2005.038232","volume":"65","author":"BM Lodde","year":"2006","unstructured":"Lodde BM et al. (2006) Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sj\u00f6gren's syndrome. Ann Rheum Dis 65: 195\u2013200","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0165_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-2005-857901","volume":"30","author":"CP Mavragani","year":"2005","unstructured":"Mavragani CP and Moutsopoulos HM (2005) Immunosuppression and immunomodulation in Sj\u00f6gren's syndrome\u2014what is the evidence? Does it relieve the sicca symptoms? Aktuelle Rheumatologie 30: 66\u201370","journal-title":"Aktuelle Rheumatologie"},{"key":"BFncprheum0165_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/rheumatology\/keh506","volume":"44","author":"LJ Dawson","year":"2005","unstructured":"Dawson LJ et al. (2005) Hydroxychloroquine therapy in patients with primary Sj\u00f6gren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford) 44: 449\u2013455","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0165_CR50","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/ard.2004.030684","volume":"64","author":"J Pijpe","year":"2005","unstructured":"Pijpe J et al. (2005) Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sj\u00f6gren's syndrome and associated MALT lymphoma. Ann Rheum Dis 64: 958\u2013960","journal-title":"Ann Rheum Dis"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:58:09Z","timestamp":1684443489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["BFncprheum0165"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0165","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}